OpGen Files to Sell Up to $11.5M of Common Stock | GenomeWeb

This article has been updated to include information from a second SEC filing, filed by OpGen on Sept. 14.

NEW YORK (GenomeWeb) – OpGen late Wednesday filed a prospectus with the US Securities and Exchange Commission to sell up to $25 million of its common stock through Cowen and Co. on the Nasdaq, with initial sales to be limited to $11.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.